The California stem cell agency today effectively approved a $13.9 million grant involving UCLA to develop stem cell gene therapy for sickle cell anemia.
CIRM directors acted on a staff recommendation to place the grant in a category that is automatically approved by the board.
(Here is a press release that was issued later by UCLA. The investigator is Donald Kohn.)
No comments:
Post a Comment